| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 139,
Authors: 409,
Journals: 57,
Outer References: 3792,
Words: 481
Collection span: 2002 - 2004
View: Overview. Sorted by year, source, volume, issue, page.
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 1 | 69 | 1 2002 AIDS 16:S17-S23 Gummuluru S; Emerman M Advances in HIV molecular biology | 0 | 0 |
| 2 | 2 | 99 | 2 2002 AIDS 16:S25-S31 Ameisen JC; Lelievre JD; Pleskoff O HIV/host interactions: new lessons from the Red Queen's country | 0 | 1 |
| 3 | 1 | 2 | 3 2002 BIOFUTUR (226):31-32 Dupin L The secret boot | 0 | 0 |
| 4 | 1 | 57 | 4 2002 JOURNAL OF VIROLOGY 76(21):11133-11138 Madani N; Millette R; Platt EJ; Marin M; Kozak SL; et al. Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1 | 10 | 10 |
| 5 | 1 | 29 | 5 2002 MOLECULAR CELL 10(5):1247-1253 Harris RS; Petersen-Mahrt SK; Neuberger MS RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators | 30 | 60 |
| 6 | 1 | 9 | 6 2002 MOLECULAR THERAPY 6(4):441-442 Bushman F A new cellular system opposing HIV infection: Implications for gene transfer? | 0 | 0 |
| 7 | 1 | 18 | 7 2002 NATURE 418(6898):594-595 Pomerantz RJ HIV - A tough viral nut to crack | 2 | 3 |
| 8 | 0 | 30 | 8 2002 NATURE 418(6898):646-650 Sheehy AM; Gaddis NC; Choi JD; Malim MH Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | 138 | 138 |
| 9 | 1 | 2 | 9 2002 NATURE REVIEWS DRUG DISCOVERY 1(9):658-658 Bell E Vif - a new therapeutic target? | 0 | 0 |
| 10 | 1 | 3 | 10 2002 SCIENTIST 16(17):40-40 Johnston N Researchers find chink in HIV-1's armor | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 11 | 1 | 10 | 11 2003 AMERICAN JOURNAL OF HUMAN BIOLOGY 15(1):118-121 Mosier DE The human immunodeficiency virus: Biology, immunology and therapy. | 0 | 0 |
| 12 | 3 | 23 | 12 2003 CELL 113(6):803-809 Harris RS; Bishop KN; Sheehy AM; Craig HM; Petersen-Mahrt SK; et al. DNA determination mediates innate immunity to retroviral infection | 66 | 86 |
| 13 | 5 | 52 | 13 2003 CELL 114(1):21-31 Mariani R; Chen D; Schrofelbauer B; Navarro F; Konig R; et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif | 61 | 72 |
| 14 | 8 | 20 | 14 2003 CELL 114(3):281-283 Goff SP Death by deamination: A novel host restriction system for HIV-1 | 7 | 9 |
| 15 | 1 | 35 | 15 2003 CELL RESEARCH 13(1):1-7 Stebbing J; Patterson S; Gotch F New insights into the immunology and evolution of HIV | 0 | 5 |
| 16 | 4 | 27 | 16 2003 CELLULAR AND MOLECULAR LIFE SCIENCES 60(10):2017-2019 Pomerantz RJ The HIV-1 Vif protein: a paradigm for viral: cell interactions | 1 | 1 |
| 17 | 1 | 150 | 17 2003 CELLULAR FACTORS INVOLVED IN EARLY STEPS OF RETROVIRAL REPLICATON 281:179-208 Dvorin JD; Malim MH Intracellular trafficking of HIV-1 cores: Journey to the center of the cell | 2 | 3 |
| 18 | 7 | 21 | 18 2003 CURRENT BIOLOGY 13(22):2009-2013 Conticello SG; Harris RS; Neuberger MS The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G | 23 | 26 |
| 19 | 2 | 144 | 19 2003 CURRENT OPINION IN MOLECULAR THERAPEUTICS 5(5):529-540 Poeschla EM Non-primate lentiviral vectors | 0 | 2 |
| 20 | 1 | 53 | 20 2003 EMBO JOURNAL 22(3):385-394 Hatziioannou T; Cowan S; Goff SP; Bieniasz PD; Towers GJ Restriction of multiple divergent retroviruses by Lv1 and Ref1 | 19 | 38 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 21 | 1 | 51 | 21 2003 EMBO JOURNAL 22(15):3971-3982 Chester A; Somasekaram A; Tzimina M; Jarmuz A; Gisbourne J; et al. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay | 1 | 14 |
| 22 | 2 | 131 | 22 2003 FRONTIERS IN BIOSCIENCE 8:D1170-D1185 Muller MC; Barre-Sinoussi F SIVagm: Genetic and biological features associated with replication | 0 | 0 |
| 23 | 1 | 37 | 23 2003 INTERNATIONAL JOURNAL OF STD & AIDS 14(10):652-655 Kandil H; Stebbing J; Gazzard B; Portsmouth S Innate and adaptive immunological insights into HIV pathogenesis | 0 | 0 |
| 24 | 2 | 39 | 24 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(8):6596-6602 Yang B; Gao L; Li L; Lu ZX; Fan XJ; et al. Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins | 3 | 4 |
| 25 | 6 | 26 | 25 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(45):44412-44416 Shindo K; Takaori-Kondo A; Kobayashi M; Abudu A; Fukunaga K; et al. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity | 8 | 9 |
| 26 | 1 | 23 | 26 2003 JOURNAL OF GENERAL VIROLOGY 84:3227-3231 Kar S; Cummings P; Alexander L Human immunodeficiency virus type 1 Vif supports efficient primate lentivirus replication in rhesus monkey cells | 0 | 0 |
| 27 | 1 | 58 | 27 2003 JOURNAL OF VIROLOGY 77(2):1131-1140 Kao S; Akari H; Khan MA; Dettenhofer M; Yu XF; et al. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection | 8 | 10 |
| 28 | 1 | 68 | 28 2003 JOURNAL OF VIROLOGY 77(5):3167-3180 Berthoux L; Towers GJ; Gurer C; Salomoni P; Pandolfi PP; et al. As2O3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity | 2 | 7 |
| 29 | 1 | 69 | 29 2003 JOURNAL OF VIROLOGY 77(10):5810-5820 Gaddis NC; Chertova E; Sheehy AM; Henderson LE; Malim MH Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions | 18 | 18 |
| 30 | 9 | 47 | 30 2003 JOURNAL OF VIROLOGY 77(21):11398-11407 Kao S; Khan MA; Miyagi E; Plishka R; Buckler-White A; et al. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity | 20 | 24 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 31 | 2 | 47 | 31 2003 JOURNAL OF VIROLOGY 77(22):12105-12112 Campbell TB; Schneider K; Wrin T; Petropoulos CJ; Connick E Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma | 0 | 2 |
| 32 | 6 | 30 | 32 2003 MOLECULAR CELL 12(3):591-601 Stopak K; de Noronha C; Yonemoto W; Greene WC HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability | 44 | 50 |
| 33 | 7 | 15 | 33 2003 MOLECULAR THERAPY 8(4):525-527 Cullen BR HIV-1 Vif: Counteracting innate antiretroviral defenses | 2 | 2 |
| 34 | 7 | 18 | 34 2003 NATURE 424(6944):21-22 Gu YP; Sundquist WI Good to CU | 6 | 6 |
| 35 | 3 | 30 | 35 2003 NATURE 424(6944):94-98 Zhang H; Yang B; Pomerantz RJ; Zhang CM; Arunachalam SC; et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA | 63 | 88 |
| 36 | 2 | 28 | 36 2003 NATURE 424(6944):99-103 Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts | 69 | 97 |
| 37 | 4 | 29 | 37 2003 NATURE IMMUNOLOGY 4(7):641-643 Harris RS; Sheehy AM; Craig HM; Malim MH; Neuberger MS DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses | 7 | 9 |
| 38 | 2 | 120 | 38 2003 NATURE MEDICINE 9(7):853-860 Stevenson M HIV-1 pathogenesis | 3 | 13 |
| 39 | 3 | 87 | 39 2003 NATURE MEDICINE 9(7):867-873 Pomerantz RJ; Horn DL Twenty years of therapy for HIV-1 infection | 1 | 10 |
| 40 | 4 | 58 | 40 2003 NATURE MEDICINE 9(7):887-891 Weiss RA HIV and AIDS: looking ahead | 0 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 41 | 3 | 27 | 41 2003 NATURE MEDICINE 9(9):1138-1143 Towers GJ; Hatziioannou T; Cowan S; Goff SP; Luban J; et al. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors | 15 | 34 |
| 42 | 8 | 40 | 42 2003 NATURE MEDICINE 9(11):1398-1403 Marin M; Rose KM; Kozak SL; Kabat D HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation | 46 | 55 |
| 43 | 5 | 25 | 43 2003 NATURE MEDICINE 9(11):1404-1407 Sheehy AM; Gaddis NC; Malim MH The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif | 47 | 52 |
| 44 | 7 | 118 | 44 2003 NATURE REVIEWS MICROBIOLOGY 1(3):181-190 Simon V; Ho DD HIV-1 dynamics in vivo: Implications for therapy | 0 | 0 |
| 45 | 1 | 35 | 45 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(3):1298-1303 Kootstra NA; Munk C; Tonnu N; Landau NR; Verma IM Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells | 4 | 17 |
| 46 | 2 | 31 | 46 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(25):15154-15159 Varthakavi V; Smith RM; Bour SP; Strebel K; Spearman P Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production | 4 | 7 |
| 47 | 1 | 5 | 47 2003 SCIENCE 300(5622):1112-1112 Lecossier D; Bouchonnet F; Clavel F; Hance AJ Hypermutation of HIV-1 DNA in the absence of the Vif protein | 55 | 66 |
| 48 | 8 | 29 | 48 2003 SCIENCE 301(5635):923-925 KewalRamani VN; Coffin JM Weapons of mutational destruction | 3 | 7 |
| 49 | 6 | 27 | 49 2003 SCIENCE 302(5647):1056-1060 Yu XH; Yu YK; Liu BD; Luo K; Kong W; et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex | 38 | 47 |
| 50 | 2 | 40 | 50 2003 SEMINARS IN IMMUNOLOGY 15(4):201-208 Hayday AC; Pennington DJ; Giuggio VM Genomics and immunology | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 51 | 2 | 62 | 51 2003 TRENDS IN BIOCHEMICAL SCIENCES 28(6):305-312 Neuberger MS; Harris RS; Di Noia J; Petersen-Mahrt SK Immunity through DNA deamination | 6 | 19 |
| 52 | 2 | 73 | 52 2003 TRENDS IN GENETICS 19(4):207-216 Wedekind JE; Dance GSC; Sowden MP; Smith HC Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business | 13 | 22 |
| 53 | 2 | 65 | 53 2003 TRENDS IN MICROBIOLOGY 11(6):286-291 Bieniasz PD Restriction factors: a defense against retroviral infection | 8 | 19 |
| 54 | 7 | 20 | 54 2003 TRENDS IN MOLECULAR MEDICINE 9(10):409-413 Vartanian JP; Sommer P; Wain-Hobson S Death and the retrovirus | 8 | 9 |
| 55 | 1 | 46 | 55 2003 VIROLOGY 313(2):653-662 Kuate S; Stahl-Hennig C; ten Haaft P; Heeney J; Uberla K Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines | 1 | 2 |
| 56 | 1 | 54 | 56 2004 AIDS 18(4):587-596 Yin JY; Chen MF; Finkel TH Differential gene expression during HIV-1 infection analyzed by suppression subtractive hybridization | 0 | 0 |
| 57 | 5 | 95 | 57 2004 AIDS 18(9):1231-1240 Nolan D; Gaudieri S; John M; Mallal S Impact of host genetics on HIV disease progression and treatment: new conflicts on an ancient battleground | 0 | 0 |
| 58 | 5 | 14 | 58 2004 AIDS 18(13):1863-1865 Min W; Hui X; Hong KX; Huang HL; Tang HL; et al. Biased G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor | 0 | 0 |
| 59 | 3 | 66 | 59 2004 AIDS RESEARCH AND HUMAN RETROVIRUSES 20(3):285-295 Swiggard WJ; O'Doherty U; McGain D; Jeyakumar D; Malim MH Long HIV type 1 reverse transcripts can accumulate stably within resting CD4(+) T cells while short ones are degraded | 1 | 1 |
| 60 | 9 | 122 | 60 2004 ARCHIVES OF VIROLOGY 149(6):1067-1082 Bukrinskaya AG HIV-1 assembly and maturation - Brief review | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 61 | 10 | 31 | 61 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 315(1):66-72 Dussart S; Courcoul M; Bessou G; Douaisi M; Duverger Y; et al. The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin | 1 | 1 |
| 62 | 2 | 42 | 62 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 320(2):544-550 Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Sakamoto A; Ishikawa K; et al. Intracellular expression of antisense RNA. transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells | 0 | 0 |
| 63 | 12 | 21 | 63 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 321(3):566-573 Douaisi M; Dussart S; Courcoul M; Bessou G; Vigne R; et al. HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles | 0 | 0 |
| 64 | 21 | 34 | 64 2004 CURRENT BIOLOGY 14(15):1385-1391 Liddament MT; Brown WL; Schumacher AJ; Harris RS APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo | 3 | 4 |
| 65 | 18 | 30 | 65 2004 CURRENT BIOLOGY 14(15):1392-1396 Bishop KN; Holmes RK; Sheehy AM; Davidson NO; Cho SJ; et al. Cytidine deamination of retroviral DNA by diverse APOBEC proteins | 4 | 5 |
| 66 | 2 | 126 | 66 2004 CURRENT HIV RESEARCH 2(3):255-270 Hout DR; Mulcahy ER; Pacyniak E; Gomez LM; Gomez ML; et al. Vpu: A multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1 | 0 | 0 |
| 67 | 4 | 100 | 67 2004 CURRENT MEDICINAL CHEMISTRY 11(2):221-231 Baraz L; Kotler M The Vif protein of human immunodeficiency virus type 1 (HIV-1): Enigmas and solutions | 0 | 0 |
| 68 | 1 | 63 | 68 2004 CURRENT OPINION IN IMMUNOLOGY 16(4):470-476 Bailey J; Blankson JN; Wind-Rotolo M; Siliciano RF Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs | 0 | 1 |
| 69 | 14 | 45 | 69 2004 CURRENT OPINION IN IMMUNOLOGY 16(4):477-482 Navarro F; Landau NR Recent insights into HIV-1 Vif | 1 | 2 |
| 70 | 13 | 37 | 70 2004 CURRENT OPINION IN MICROBIOLOGY 7(4):407-411 Trkola A HIV-host interactions: vital to the virus and key to its inhibition | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 71 | 13 | 38 | 71 2004 CURRENT OPINION IN MICROBIOLOGY 7(5):555-559 Trkola A HIV-host interactions: vital to the virus and key to its inhibition (vol 7, pg 555, 2004) | 1 | 1 |
| 72 | 7 | 237 | 72 2004 CURRENT PHARMACEUTICAL DESIGN 10(30):3725-3739 Muriaux D; Darlix JL; Cimarelli A Targeting the assembly of the human immunodeficiency virus type I | 0 | 1 |
| 73 | 10 | 29 | 73 2004 DNA REPAIR 3(1):85-89 Bhagwat AS DNA-cytosine deaminases: from antibody maturation to antiviral defense | 0 | 1 |
| 74 | 14 | 32 | 74 2004 EMBO JOURNAL 23(12):2451-2458 Wiegand HL; Doehle BP; Bogerd HP; Cullen BR A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins | 6 | 7 |
| 75 | 2 | 73 | 75 2004 EMBO JOURNAL 23(13):2632-2640 Swanson CM; Puffer BA; Ahmad KM; Doms RW; Malim MH Retroviral mRNA nuclear export elements regulate protein function and virion assembly | 0 | 1 |
| 76 | 16 | 23 | 76 2004 EMBO REPORTS 5(7):679-680 Trono D Retroviruses under editing crossfire - A second member of the human APOBEC3 family is a Vif-blockable innate antiretroviral factor | 0 | 0 |
| 77 | 6 | 47 | 77 2004 FEBS LETTERS 563(1-3):170-178 Zhao LJ; Jian H; Zhu HH HIV-1 auxiliary regulatory protein Vpr promotes ubiquitination and turnover of Vpr mutants containing the L64P mutation | 0 | 0 |
| 78 | 3 | 67 | 78 2004 FOLIA BIOLOGICA 50(3-4):78-86 Weiss RA Cancer, infection and immunity: A personal homage to Jan Svoboda | 0 | 0 |
| 79 | 1 | 69 | 79 2004 FRONTIERS IN BIOSCIENCE 9:370-377 Kanzaki LIB; Looney DJ Feline immunodeficiency virus: A concise review | 0 | 0 |
| 80 | 2 | 151 | 80 2004 FRONTIERS IN BIOSCIENCE 9:521-539 Chakrabarti LA The paradox of simian immunodeficiency virus infection in sooty mangabeys: Active viral replication without disease progression | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 81 | 12 | 326 | 81 2004 FRONTIERS IN BIOSCIENCE 9:2388-2413 Seelamgari A; Maddukuri A; Berro R; de la Fuente C; Kehn K; et al. Role of viral regulatory and accessory proteins in HIV-1 replication | 0 | 0 |
| 82 | 17 | 50 | 82 2004 HUMAN MOLECULAR GENETICS 13(16):1785-1791 Zhang JZ; Webb DM Rapid evolution of primate antiviral enzyme APOBEC3G | 1 | 2 |
| 83 | 11 | 39 | 83 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(9):7792-7798 Mehle A; Strack B; Ancuta P; Zhang CS; McPike M; et al. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway | 12 | 13 |
| 84 | 14 | 46 | 84 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(13):12355-12362 Akari H; Fujita M; Kao S; Khan MA; Shehu-Xhilaga M; et al. High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the gag precursor at the p2/nucleocapsid processing site | 1 | 2 |
| 85 | 10 | 17 | 85 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(15):14481-14483 Mangeat B; Turelli P; Liao SY; Trono D A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to vif action | 9 | 10 |
| 86 | 17 | 53 | 86 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(32):33177-33184 Cen S; Guo F; Niu MJ; Saadatmand J; Deflassieux J; et al. The interaction between HIV-1 Gag and APOBEC3G | 3 | 4 |
| 87 | 21 | 33 | 87 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(33):34083-34086 Alce TM; Popik W APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein | 2 | 2 |
| 88 | 15 | 33 | 88 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(34):35822-35828 Svarovskaia ES; Xu HZ; Mbisa JL; Barr R; Gorelick RJ; et al. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 Virions through interactions with viral and nonviral RNAs | 2 | 3 |
| 89 | 17 | 62 | 89 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(40):41744-41749 Rose KM; Marin M; Kozak SL; Kabat D Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus | 0 | 0 |
| 90 | 10 | 29 | 90 2004 JOURNAL OF CELLULAR BIOCHEMISTRY 92(3):560-572 Li JL; Potash MJ; Volsky DJ Functional domains of APOBEC3G required for antiviral activity | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 91 | 3 | 165 | 91 2004 JOURNAL OF GENE MEDICINE 6:S67-S82 Pages JC; Bru T Toolbox for retrovectorologists | 0 | 1 |
| 92 | 2 | 158 | 92 2004 JOURNAL OF GENE MEDICINE 6:S95-S104 Saenz DT; Poeschla EM FIV: from lentivirus to lentivector | 0 | 2 |
| 93 | 11 | 80 | 93 2004 JOURNAL OF IMMUNOLOGY 172(11):6513-6518 Cascalho M Advantages and disadvantages of cytidine deamination | 0 | 0 |
| 94 | 1 | 15 | 94 2004 JOURNAL OF INFECTIOUS DISEASES 189(12):2181-2184 Cavert W; Webb CH; Balfour HH Alterations in the C-terminal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy | 0 | 0 |
| 95 | 2 | 58 | 95 2004 JOURNAL OF MOLECULAR BIOLOGY 340(3):525-542 da Silva FA; Santa-Marta M; Freitas-Vieira A; Mascarenhas P; Barahona I; et al. Camelized rabbit-derived VH single-domain Intrabodies Against vif strongly neutralize HIV-1 infectivity | 0 | 0 |
| 96 | 7 | 171 | 96 2004 JOURNAL OF MOLECULAR MEDICINE-JMM 82(5):280-297 Krokan HE; Kavli B; Slupphaug G Novel aspects of macromolecular repair and relationship to human disease | 0 | 2 |
| 97 | 14 | 66 | 97 2004 JOURNAL OF VIROLOGY 78(4):2072-2081 Liu BD; Yu XH; Luo K; Yu YK; Yu XF Influence of primate lentiviral vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G | 9 | 9 |
| 98 | 6 | 46 | 98 2004 JOURNAL OF VIROLOGY 78(11):6005-6012 Hatziioannou T; Cowan S; von Schwedler UK; Sundquist WI; Bieniasz PD Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid | 0 | 0 |
| 99 | 14 | 37 | 99 2004 JOURNAL OF VIROLOGY 78(11):6073-6076 Zheng YH; Irwin D; Kurosu T; Tokunaga K; Sata T; et al. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication | 9 | 10 |
| 100 | 3 | 54 | 100 2004 JOURNAL OF VIROLOGY 78(14):7565-7574 Pastore C; Ramos A; Mosier DE Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 101 | 15 | 33 | 101 2004 JOURNAL OF VIROLOGY 78(15):8238-8244 Kobayashi M; Takaori-Kondo A; Shindo K; Abudu A; Fukunaga K; et al. APOBEC3G targets specific virus species | 1 | 1 |
| 102 | 5 | 53 | 102 2004 JOURNAL OF VIROLOGY 78(16):8799-8811 Garcin D; Marq JB; Iseni F; Martin S; Kolakofsky D A short peptide at the amino terminus of the Sendai virus C protein acts as an independent element that induces STAT1 instability | 0 | 0 |
| 103 | 11 | 45 | 103 2004 JOURNAL OF VIROLOGY 78(19):10574-10581 Feng F; Davis A; Lake JA; Carr J; Xia W; et al. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif | 0 | 0 |
| 104 | 7 | 42 | 104 2004 JOURNAL OF VIROLOGY 78(19):10747-10754 Ciuffi A; Bleiber G; Munoz M; Martinez R; Loeuillet C; et al. Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection | 0 | 0 |
| 105 | 9 | 33 | 105 2004 JOURNAL OF VIROLOGY 78(20):11070-11076 An P; Bleiber G; Duggal P; Nelson G; May M; et al. APOBEC3G genetic variants and their influence on the progression to AIDS | 0 | 0 |
| 106 | 1 | 55 | 106 2004 JOURNAL OF VIROLOGY 78(20):11130-11141 Marozsan AJ; Fraundorf E; Abraha A; Baird H; Moore D; et al. Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates | 0 | 0 |
| 107 | 2 | 64 | 107 2004 JOURNAL OF VIROLOGY 78(20):11303-11312 Bennett EM; Lever AML; Allen JF Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2 | 0 | 0 |
| 108 | 2 | 32 | 108 2004 JOURNAL OF VIROLOGY 78(21):11715-11725 Evans DT; Bricker JE; Desrosiers RC A novel approach for producing Lentiviruses that are limited to a single cycle of infection | 0 | 0 |
| 109 | 11 | 45 | 109 2004 JOURNAL OF VIROLOGY 78(21):11816-11822 Ikeda Y; Ylinen LMJ; Kahar-Bador M; Towers GJ Influence of gag on human immunodeficiency virus type 1 species-specific tropism | 0 | 0 |
| 110 | 18 | 96 | 110 2004 JOURNAL OF VIROLOGY 78(21):11841-11852 Luo K; Liu BD; Xiao ZX; Yu YK; Yu XH; et al. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 111 | 21 | 49 | 111 2004 JOURNAL OF VIROLOGY 78(21):12041-12046 Gaddis NC; Sheehy AM; Ahmad KM; Swanson CM; Bishop KN; et al. Further investigation of simian immunodeficiency virus vif function in human cells | 0 | 0 |
| 112 | 14 | 24 | 112 2004 JOURNAL OF VIROLOGY 78(21):12058-12061 Zennou W; Perez-Caballero D; Gottlinger H; Bieniasz PD APOBEC3G incorporation into human immunodeficiency virus type 1 particles | 0 | 0 |
| 113 | 7 | 81 | 113 2004 JOURNAL OF VIROLOGY 78(22):12537-12547 Baumann JG; Unutmaz D; Miller MD; Breun SKJ; Grill SM; et al. Murine T cells potently restrict human immunodeficiency virus infection | 0 | 0 |
| 114 | 10 | 10 | 114 2004 M S-MEDECINE SCIENCES 20(2):139-141 Schwartz O HIV-1, a very Vif virus | 0 | 0 |
| 115 | 2 | 39 | 115 2004 MICROBES AND INFECTION 6(9):799-805 Sakurai A; Jere A; Yoshida A; Yamada T; Iwamoto A; et al. Functional analysis of HIV-1 vif genes derived from Japanese long-term nonprogressors and progressors for AIDS | 0 | 0 |
| 116 | 6 | 10 | 116 2004 NATURE IMMUNOLOGY 5(4):355-356 Stevenson M TRIMming HIV-1's mainsail | 0 | 0 |
| 117 | 5 | 20 | 117 2004 NATURE IMMUNOLOGY 5(9):867-871 Greene W The brightening future of HIV therapeutics | 0 | 0 |
| 118 | 29 | 101 | 118 2004 NATURE IMMUNOLOGY 5(11):1109-1115 Bieniasz PD Intrinsic immunity: a front-line defense against viral attack | 0 | 0 |
| 119 | 4 | 15 | 119 2004 NATURE MEDICINE 10(8):778-780 Greene WC Redistricting the retroviral restriction factors | 0 | 0 |
| 120 | 1 | 2 | 120 2004 NATURE MEDICINE 10(11):1175-1175 [Anon] Host-virus battle lines redrawn | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 121 | 34 | 106 | 121 2004 NATURE REVIEWS IMMUNOLOGY 4(11):868-877 Harris RS; Liddament MT Retroviral restriction by APOBEC proteins | 0 | 0 |
| 122 | 12 | 36 | 122 2004 NATURE STRUCTURAL & MOLECULAR BIOLOGY 11(5):435-442 Yu Q; Konig R; Pillai S; Chiles K; Kearney M; et al. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome | 10 | 11 |
| 123 | 20 | 59 | 123 2004 NUCLEIC ACIDS RESEARCH 32(8):2421-2429 Suspene R; Sommer P; Henry M; Ferris S; Guetard D; et al. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase | 0 | 0 |
| 124 | 2 | 23 | 124 2004 PLOS BIOLOGY 2(9):1267-1269 Holmes EC Adaptation and immunity | 0 | 0 |
| 125 | 17 | 50 | 125 2004 PLOS BIOLOGY 2(9):1278-1285 Sawyer SL; Emerman M; Malik HS Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G | 0 | 0 |
| 126 | 14 | 24 | 126 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(11):3725-3726 Kaiser SM; Emerman M Controlling lentiviruses: Single amino acid changes can determine specificity | 0 | 0 |
| 127 | 13 | 28 | 127 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(11):3770-3774 Bogerd HP; Doehle BP; Wiegand HL; Cullen BR A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor | 15 | 16 |
| 128 | 14 | 30 | 128 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(11):3927-3932 Schrofelbauer R; Chen D; Landau NR A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif) | 0 | 0 |
| 129 | 14 | 32 | 129 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(15):5652-5657 Xu HZ; Svarovskaia ES; Barr R; Zhang YJ; Khan MA; et al. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion | 8 | 8 |
| 130 | 3 | 54 | 130 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(21):8114-8119 Xie KF; Sowden MP; Dance GSC; Torelli AT; Smith HC; et al. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1 | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 131 | 7 | 37 | 131 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(29):10774-10779 Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5 alpha | 1 | 4 |
| 132 | 10 | 42 | 132 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(29):10780-10785 Keckesova Z; Ylinen LMJ; Towers GJ The human and African green monkey TRIM5 alpha genes encode Ref1 and Lv1 retroviral restriction factor activities | 2 | 5 |
| 133 | 8 | 19 | 133 2004 REVIEWS IN MEDICAL VIROLOGY 14(1):1-2 Griffiths PD From restriction factors to restriction enzymes | 0 | 0 |
| 134 | 3 | 11 | 134 2004 SCIENCE 305(5689):1403A-+ Rosler C; Kock J; Malim MH; Blum HE; von Weizsacker F Comment on "Inhibition of hepatitis B virus replication by APOBEC3G" | 0 | 0 |
| 135 | 1 | 1 | 135 2004 SCIENTIST 18(11):14-14 Malim MH; Sheehy AM Finding the Achilles' heel of AIDS | 0 | 0 |
| 136 | 12 | 24 | 136 2004 TRENDS IN MICROBIOLOGY 12(4):145-148 Argyris EG; Pomerantz RJ HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host | 0 | 0 |
| 137 | 9 | 70 | 137 2004 TRENDS IN MICROBIOLOGY 12(4):170-177 Freed EO HIV-1 and the host cell: an intimate association | 0 | 0 |
| 138 | 21 | 70 | 138 2004 TRENDS IN MOLECULAR MEDICINE 10(6):291-297 Rose KM; Marin M; Kozak SL; Kabat D The viral infectivity factor (Vif) of HIV-1 unveiled | 1 | 1 |
| 139 | 7 | 57 | 139 2004 VIROLOGY 318(1):350-359 Kristbjornsdottir HB; Andresdottir V; Svansson V; Torsteinsdottir S; Matthiasdottir S; et al. The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro | 0 | 0 |
Generated by: HistCite 2004.11.12